DENVER—The rise of healthcare apps and digital therapeutics has made it easier than ever for patients with inflammatory bowel disease to access information about their health, but it also has prompted efforts to optimize the value of these products.
During the 2023 Crohn’s and Colitis Congress, Megan E. Riehl, PsyD, the clinical director of the GI Behavioral Health Program at University of Michigan Health, in Ann Arbor, and Lawrence R. Kosinski, MD, MBA, the founder and chief medical